Home »
1995 Issues »
60 FR (08/18/1995) » 95-20564. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products; Correction
95-20564. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products; Correction
[Federal Register Volume 60, Number 160 (Friday, August 18, 1995)]
[Proposed Rules]
[Page 43091]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20564]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 310 and 341
[Docket No. 94N-0247]
RIN 0905-AA06
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug
Products for Over-the-Counter Human Use; Proposed Amendment of
Monograph for OTC Bronchodilator Drug Products; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of proposed rulemaking; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a
proposal that appeared in the Federal Register of March 9, 1995 (60 FR
13014). That document proposed to amend the final monograph for over-
the-counter (OTC) bronchodilator drug products to remove pressurized
metered-dose aerosol container dosage forms for the ingredients
epinephrine, epinephrine bitartrate, and racepinephrine hydrochloride.
The document was published with two errors. This document corrects
those errors.
FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD
20857, 301-443-2994.
SUPPLEMENTARY INFORMATION: In FR Doc. 95-5825, appearing on page 13014
in the Federal Register of March 8, 1995, the following corrections are
made:
Sec. 310.545 [Corrected]
1. On page 13020, in the third column, in Sec. 310.545 Drug
products containing certain active ingredients offered over-the-counter
(OTC) for certain uses, in paragraph (a)(6)(iv)(C), the words ``April
10, 1995'' are corrected to read ``(date 30 days after date of
publication of the final rule)''; and in paragraph (d)(26), the words
``April 10, 1995'' are corrected to read ``(Date 30 days after date of
publication of the final rule)''.
Dated: August 14, 1995.
William K. Hubbard,
Acting Deputy Commissioner for Policy.
[FR Doc. 95-20564 Filed 8-17-95; 8:45 am]
BILLING CODE 4160-01-F
Document Information
- Published:
- 08/18/1995
- Department:
- Food and Drug Administration
- Entry Type:
- Proposed Rule
- Action:
- Notice of proposed rulemaking; correction.
- Document Number:
- 95-20564
- Pages:
- 43091-43091 (1 pages)
- Docket Numbers:
- Docket No. 94N-0247
- RINs:
- 0905-AA06
- PDF File:
-
95-20564.pdf